Suppr超能文献

[自体献血与异体输血——成本效益分析]

[Autologous blood donation versus homologous blood transfusion--an analysis of cost effectiveness].

作者信息

Dietrich G V

机构信息

Abteilung Anaesthesiologie und Operative Intensivmedizin, Justus-Liebig-Universität Giessen.

出版信息

Zentralbl Chir. 1996;121(10):841-6.

PMID:9019932
Abstract

Cost-efficiency analysis for autologous transfusions begins with the calculation of the pure production costs. They amount to $35-$75 for one unit of red blood cell concentrate (RBC). One homologous RBC is billed with $80 in Germany. Following factors further increase costs of an autologous blood predeposit: Autologous blood frequently is transfused more generously. The expiration-rate of autologous blood is higher. The haemoglobin content of the second and following RBC is lower. The patient himself has lower haemoglobin on the day of surgery after an autologous blood donation. In scientific examinations it is possible to refer additional costs of autologous blood to a gained "quality adjusted life year". They amount to $40,000 to $1,800,000.

摘要

自体输血的成本效益分析始于纯生产成本的计算。每单位浓缩红细胞(RBC)的成本为35 - 75美元。在德国,一单位同种异体RBC的收费为80美元。以下因素会进一步增加自体血预存的成本:自体血的输注量通常更大;自体血的过期率更高;第二次及后续RBC的血红蛋白含量更低;自体献血后,患者在手术当天的血红蛋白水平更低。在科学研究中,可以将自体血的额外成本与获得的“质量调整生命年”相关联。这些成本在40,000美元至1,800,000美元之间。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验